Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

213 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

NCT01499303

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Denver, Colorado, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Sarasota, Florida, United States
View all 21 locations
View Trial Details
Completed

Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

NCT01040871

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Universitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de verdiep- polikliniek Hematologie Ghent, Belgium
View Trial Details
Completed

Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

NCT01361191

Conditions
Diffuse Large B-cell Lymphoma, Follicular Grade 3B Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • ICO- Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital de Jerez Jerez de la Frontera, Cádiz, Spain
  • Hospital Clínico Univ. de Santiago Santiago de Compostela, Galicia, Spain
View all 19 locations
View Trial Details
Completed

Multicentre Study to Determine the Cardiotoxicity of R-CHOP Compared to R-COMP in Patients With Diffuse Large B-Cell Lymphoma

NCT00575406

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Landeskrankenhaus Feldkirch Feldkirch, Austria
  • Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
  • A.ö. Landeskrankenhaus Leoben Leoben, Austria
  • Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria
View Trial Details

Related conditions